丽珠医药(01513)9月24日斥资499.77万元回购12.83万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, intending to repurchase 128,300 A-shares at a cost of 4.9977 million yuan by September 24, 2025 [1] Group 1 - The company plans to spend 4.9977 million yuan for the buyback [1] - The total number of shares to be repurchased is 128,300 [1] - The buyback is scheduled to be completed by September 24, 2025 [1]